Answer
The electrocardiogram (Fig. 1) shows a sinus tachycardia with third-degree atrioventricular block. Two very broad QRS complexes with identical morphology occur with regular intervals (V1 and V2). These complexes are caused by antegrade conduction of consecutive sinus beats a1 and a2 entirely over the accessory pathway, resulting in a fully pre-excited QRS complex. The following sinus beats (a3 and a4) are not conducted due to refractoriness of the accessory pathway and either retrograde invasion of the left posterior fascicle (LPF) by the previous conducted sinus beats or consistent antegrade atrioventricular block. The possibility of an intermittent antidromic circus movement tachycardia seemed less likely, due to strictly regular p‑p intervals. Atrioventricular conduction was improved after administration of isoprenaline (Fig. 2), and resulted in 1:1 conduction of sinus beats alternating between the His-Purkinje system and accessory pathway, the latter QRS complex being slightly narrower than before as a result of fusion with native conduction. Obviously, flecainide was discontinued and the patient was planned for definitive pacemaker implantation prior to electrophysiology studies.
Fig. 1 [Images not available. See PDF.]
Electrocardiogram on admission after syncope
Fig. 2 [Images not available. See PDF.]
Electrocardiogram after isoprenaline
In patients with Wolff-Parkinson-White syndrome, flecainide mainly prolongs the refractoriness of the accessory pathway and is used to prevent atrial tachyarrhythmias (e.g. atrial fibrillation) from rapidly conducting in the presence of a ‘malignant’ pathway [1]. However, flecainide may lead to third-degree atrioventricular block, especially in patients with advanced conduction disease. Fortunately for this patient, asystole was presumably averted by preserved atrioventricular conduction over a ‘life-saving’ accessory pathway. We must emphasise that caution is advised prescribing flecainide to patients with pre-existent chronic bifascicular block.
Conflict of interest
H.J. te Kolste, G.J. Kimman, T. Germans and S.A.J. Timmer declare that they have no competing interests.
References
1. Andrikopoulos, GK; Pastromas, S; Tzeis, S. Flecainide: Current status and perspectives in arrhythmia management. World J Cardiol; 2015; 7,
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Details
1 Amsterdam University Medical Center, Location VU Medical Center, Amsterdam, The Netherlands
2 North-West Hospital Group, Alkmaar, The Netherlands